CHECKPOINT THERAPEUTICS

Checkpoint Therapeutics was a clinical-stage company that focused on acquiring, developing, and commercializing novel immunotherapy and targeted oncology treatments for solid tumors, with a focus on accelerating the development of drugs for patients.